These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 4136288

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Granulocyte clearance and granulocyte kinetics in myeloproliferative syndromes].
    Jungi WF, Meuret G, Senn HJ.
    Schweiz Med Wochenschr; 1974 Jan 26; 104(4):133-5. PubMed ID: 4521299
    [No Abstract] [Full Text] [Related]

  • 23. Monitoring trace elements in cells from the blood of patients with acute myeloblastic, chronic lymphocytic and chronic granulocytic leukemia.
    Aleksandrowicz J, Dobrowolski JW, Balechala P, Lisiewicz J.
    Haematologica; 1982 Jun 26; 67(3):437-41. PubMed ID: 6815003
    [No Abstract] [Full Text] [Related]

  • 24. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
    Meier EC, Grob PJ.
    Dtsch Med Wochenschr; 1972 Jun 23; 97(25):967-71. PubMed ID: 4624059
    [No Abstract] [Full Text] [Related]

  • 25. The use of etiocholanolone for the measurement of marrow granulocyte reserves.
    Gunz FW, Mani MK, Ravich RB, Speden J, Vincent PC.
    Med J Aust; 1970 Apr 11; 1(15):763-7. PubMed ID: 4914293
    [No Abstract] [Full Text] [Related]

  • 26. Causes of thrombocytopenia in a hospital population. A six-months survey of 7,750 patients.
    Pembrey RG, Handley DA, Kimber RJ.
    Med J Aust; 1971 Mar 13; 1(11):583-8. PubMed ID: 5279464
    [No Abstract] [Full Text] [Related]

  • 27. Tissue culture of bone marrow. 3. Myelostimulatory factors in serum of patients with myeloproliferative diseases.
    Reisner EH.
    Cancer; 1967 Oct 13; 20(10):1679-88. PubMed ID: 5234302
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Survival and sequestration of 51Cr- and 99mTcO4-labeled platelets.
    Uchida T, Yasunaga K, Kariyone S, Wakisaka G.
    J Nucl Med; 1974 Sep 13; 15(9):801-7. PubMed ID: 4528003
    [No Abstract] [Full Text] [Related]

  • 30. [Myelofibrosis during hematologic diseases. Apropos of 402 cases].
    Devred C, Diebold J.
    Sem Hop; 1974 May 20; 50(24):1625-34. PubMed ID: 4373832
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Morphometric analysis of thrombocyte ultrastructure in healthy persons and in patients with acute leukemia, chronic myeloleukosis and myelofibrosis].
    Vashkinel' VK, Petrov MN.
    Probl Gematol Pereliv Krovi; 1981 Apr 20; 26(4):30-3. PubMed ID: 6940116
    [No Abstract] [Full Text] [Related]

  • 33. [Glycosaminoglycans of human thrombocytes in normal conditions, in chronic myeloid leukosis, myelofibrosis and polycythemia vera].
    Kharchenko MF.
    Vopr Med Khim; 1973 Apr 20; 19(6):613-7. PubMed ID: 4277844
    [No Abstract] [Full Text] [Related]

  • 34. Acute leukemia as a terminal event in nonleukemic hematopoietic disorders.
    Bloomfield CD, Brunning RD.
    Semin Oncol; 1976 Sep 20; 3(3):297-317. PubMed ID: 790581
    [No Abstract] [Full Text] [Related]

  • 35. [Comparative study of P.A.S. on a level with the red cell series in 187 normal subjects and those with a blood disease].
    Grozdéa J, Colombiès P, Ducos J.
    Rev Fr Etud Clin Biol; 1968 Feb 20; 13(2):190-5. PubMed ID: 4172572
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Elective splenectomy for primary hematologic and splenic disease.
    Devlin HB, Evans DS, Birkhead JS.
    Surg Gynecol Obstet; 1970 Aug 20; 131(2):273-6. PubMed ID: 5270604
    [No Abstract] [Full Text] [Related]

  • 38. [Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].
    Leupin L, Beck EA, Furlan M, Bucher U.
    Schweiz Med Wochenschr; 1983 May 14; 113(19):713-6. PubMed ID: 6603016
    [Abstract] [Full Text] [Related]

  • 39. [Results of the surgical treatment of patients with hematologic diseases].
    Gaĭbatov SP, Abdulaev MA.
    Vestn Khir Im I I Grek; 1988 Apr 14; 140(4):122-4. PubMed ID: 3166549
    [Abstract] [Full Text] [Related]

  • 40. Serum beta-2-microglobulin in disorders of myeloid proliferation.
    Norfolk DR, Child JA, Roberts BE, Forbes MA, Cooper EH.
    Acta Haematol; 1983 Apr 14; 69(6):361-8. PubMed ID: 6190339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.